PF-05212377 (SAM-760)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-05212377 (SAM-760), covering 2011-03-10 to 2011-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760) [Phase 1]